Hsbc Holdings PLC bought a new position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the second quarter, according to its most recent disclosure with the SEC. The firm bought 35,563 shares of the company's stock, valued at approximately $1,045,000.
Other institutional investors have also recently made changes to their positions in the company. EverSource Wealth Advisors LLC increased its holdings in Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company's stock worth $32,000 after acquiring an additional 497 shares in the last quarter. Allworth Financial LP purchased a new position in Acadia Healthcare during the second quarter valued at approximately $45,000. Wells Fargo & Company MN boosted its position in shares of Acadia Healthcare by 208.9% in the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company's stock worth $32,000 after purchasing an additional 1,510 shares during the period. Global Retirement Partners LLC purchased a new stake in shares of Acadia Healthcare in the second quarter worth $68,000. Finally, Quantbot Technologies LP purchased a new position in shares of Acadia Healthcare during the 2nd quarter valued at $88,000.
Analysts Set New Price Targets
Several research firms have weighed in on ACHC. Cantor Fitzgerald restated a "neutral" rating on shares of Acadia Healthcare in a research note on Wednesday, July 29th. UBS Group boosted their target price on shares of Acadia Healthcare from $31.00 to $39.00 and gave the stock a "buy" rating in a report on Thursday, July 9th. Weiss Ratings reaffirmed a "sell (d)" rating on shares of Acadia Healthcare in a research note on Wednesday. Jefferies Financial Group upgraded shares of Acadia Healthcare from a "hold" rating to a "buy" rating and lifted their price target for the company from $24.50 to $30.00 in a report on Wednesday, June 3rd. Finally, KeyCorp increased their price objective on shares of Acadia Healthcare from $30.00 to $40.00 and gave the company an "overweight" rating in a report on Tuesday, July 14th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company's stock. According to data from MarketBeat, Acadia Healthcare currently has a consensus rating of "Hold" and an average target price of $29.85.
Check Out Our Latest Report on ACHC
Acadia Healthcare Price Performance
Shares of Acadia Healthcare stock opened at $28.36 on Monday. The stock has a market cap of $2.64 billion, a price-to-earnings ratio of -2.28, a price-to-earnings-growth ratio of 9.14 and a beta of 0.62. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.57 and a current ratio of 1.57. The stock has a 50 day moving average price of $30.47 and a 200-day moving average price of $26.98. Acadia Healthcare Company, Inc. has a one year low of $11.43 and a one year high of $35.83.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.03. The business had revenue of $865.84 million for the quarter, compared to the consensus estimate of $844.19 million. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The business's revenue for the quarter was down .4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.83 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Equities analysts expect that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current year.
Acadia Healthcare Profile
(
Free Report)
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The company operates facilities that offer treatment for mental health conditions, substance use disorders and other behavioral health needs. Its services are designed for children, adolescents and adults and may include inpatient psychiatric care, residential treatment, outpatient programs and specialized care.
Acadia's facilities provide a range of treatment programs, including psychiatric hospitals, addiction treatment centers, eating disorder programs and other specialty behavioral healthcare services.
Further Reading
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.
